Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 2, 2015, Pages 178-186

  Alosco, Michael L ^a   Spitznagel, Mary Beth ^a,b   Sweet, Lawrence H ^c   Josephson, Richard ^d,e,f   Hughes, Joel ^a,b   Gunstad, John ^a  

^a KENT STATE UNIVERSITY   (United States)

^b AKRON CITY HOSPITAL   (United States)

^c University of Georgia ^*  (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e Harrington Heart and Vascular Institute   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; cerebral blood flow; cognitive function; Heart failure

Indexed keywords

AGED; ARTICLE; BLOOD FLOW VELOCITY; BOSTON NAMING TEST; BRAIN BLOOD FLOW; BRAIN PERFUSION; CALIFORNIA VERBAL LEARNING TEST II; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE EXACERBATION; DOPPLER ECHOGRAPHY; EXECUTIVE FUNCTION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEMORY; MIDDLE CEREBRAL ARTERY; MINI MENTAL STATE EXAMINATION; MODIFIED MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGIC TEST; RECALL; TASK PERFORMANCE; AGE DISTRIBUTION; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COMORBIDITY; DISEASE COURSE; INCIDENCE; MIDDLE AGED; RISK FACTOR; SEX RATIO; UNITED STATES; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CAUSALITY; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 84922708204     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12543     Document Type: Article

References (55)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014; 129: e28-e292.
2. Rogers JK, Pocock SJ, McMurray JJ, Granger CB, Michelson EL, Ostergen J, Pfeffer MA, et al. Analysing recurrent hospitalizations in heart failure: A review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail 2014; 16: 33-40.
3. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L,. Heart failure and risk of dementia and Alzheimer's disease: A population-based cohort study. Arch Intern Med 2006; 166: 1003-1008.
4. Hjelm C, Brostrom A, Dahl A, Johansson B, Fredrikson M, Stromberg A,. Factors associated with increased risk for dementia in individuals age 80 years or older with congestive heart failure. J Cardiovasc Nurs 2014; 29: 82-90.
5. Pan A, Kumar R, Macey PM, Fonarow GC, Harper RM, Woo MA,. Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. J Card Fail 2013; 19: 94-100.
6. Woo MA, Macey PM, Keens PT, Kumar R, Fonarow GC, Hamilton MA, Harper RM, et al. Aberrant central nervous system responses to the Valsalva maneuver in heart failure. Congest Heart Fail 2007; 13: 29-35.
7. Hajduk AM, Lemon SC, McManus DD, Lessard DM, Gurwitz JH, Spencer FA, Goldberg RJ, et al. Cognitive impairment and self-care in heart failure. Clin Epidemiol 2013; 5: 407-416.
8. Pressler SJ, Subramanian U, Kareken D, Perkins SM, Gradus-Pizlo I, Sauve MJ, Ding Y, et al. Cognitive deficits in chronic heart failure. Nurs Res 2010; 59: 127-139.
9. Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, Lo Monaco MR, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003; 115: 97-103.
10. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, Aldershvile J,. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001; 32: 2530-2533.
11. Alosco ML, Brickman AM, Spitznagel MB, Garcia SL, Narkhede A, Griffith EY, Raz N, et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail 2013; 19: E29-E34.
12. Alosco ML, Spitznagel MB, Gunstad J,. Obesity as a risk factor for poor neurocognitive outcomes in older adults with heart failure. Heart Fail Rev 2014; 19: 403-411.
13. Birdsill AC, Carlsson CM, Willete AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring) 2013; 21: 1313-1320.
14. Yadav SK, Kumar R, Macey PM, Richardson HL, Wang DJ, Woo MA, Harper RM,. Regional cerebral blood flow alterations in obstructive sleep apnea. Neurosci Lett 2013; 555: 159-164.
15. Novak V, Last D, Alsop DC, Abduljalil AM, Hu K, Lepicovsky L, Cavallerano J, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006; 29: 1529-1534.
16. Fujishima M, Ibayahsi S, Fuji K, Mori S,. Cerebral blood flow and brain function in hypertension. Hypertens Res 1995; 18: 111-117.
17. Alosco ML, Spitznagel MB, Raz N, Cohen R, Sweet LH, Colbert LH, Josephson R, et al. Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure. Cerebrovasc Dis Extra 2012; 2: 88-98.
18. Alosco ML, Brickman AM, Spitznagel MB, Griffith EY, Narkhede A, Raz N, Cohen R, et al. Independent and interactive effects of blood pressure and cardiac function on brain volume and white matter hyperintensities in heart failure. J Am Soc Hypertens 2013; 7: 336-343.
19. Anter E, Jessup M, Callans DJ,. Contemporary reviews in cardiovascular medicine: Atrial fibrillation and heart failure treatment considerations for a dual epidemic. Circulation 2009; 119: 2516-2525.
20. Maisel WH, Stevenson LW,. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D-8D.
21. Khazanie P, Liang L, Qualis LG, Curtis LH, Fonarow GC, Hammill BG, Hammill SC, et al. Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. JACC Heart Fail 2014; 2: 41-48.
22. Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006; 97: 1365-1369.
23. Gaita F, Corsinovi L, Anselmino M, Raimondo C, Pianelli M, Toso E, Bergamasco L, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol 2013; 62: 1990-1997.
24. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A,. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997; 28: 316-321.
25. Udompanich S, Lip GY, Apostolakis S, Lane DA,. Atrial fibrillation as a risk factor for cognitive impairment: A semi-systematic review. QJM 2013; 106: 795-802.
26. Teng EL, Chui HC,. The Modified Mini-Mental State Examination. J Clin Psychiatry 1987; 48: 314-318.
27. Reitan R,. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 1958; 8: 271-276.
28. Smith A,. Clinical psychological practice and principals of neuropsychological assessment. In:, Walker C, (ed.): Handbook of Clinical Psychology: Theory, Research, and Practice. Homewood, IL: Dorsey Press, 1983:445-500.
29. Dubois B, Slachevsky A, Litvan I, Pillon B,. The FAB: A frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
30. Delis D, Kramer J, Kaplan E, Ober B,. California Verbal Learning Test-Second Edition: Adult Version, Manual. San Antonio, TX, Psychological Corporation, 2000.
31. Kaplan E, Goodglass H, Weintraub, S,. Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
32. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimers disease. Neurology 1989; 39: 1159-1165.
33. Bulas D, Jones A, Seibert J, Driscoll C, O'Donnell R, Adams RJ,. Transcranial Doppler (TCD) screening for stroke prevention I sickle cell anemia: Pitfalls in technique variation. Pediat Radiol 2000; 30: 733-738.
34. Sorond FA, Hollenberg NK, Panych LP, Fisher ND,. Brain blood flow and velocity: Correlations between magnetic resonance imaging and transcranial Doppler sonography. J Ultrasound Med 2010; 29: 1017-1022.
35. Bishop CC, Powell S, Rutt D, Browse NL,. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: A validation study. Stroke 1986; 17: 913-915.
36. O'Connel JE, Gray CS, French JM, Robertson IH,. Atrial fibrillation and cognitive function: Case-control study. J Neurol Neurosurg Psychiat. 1998; 65: 386-389.
37. Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, McCormick W, et al. Atrial fibrillation and risk of dementia: A prospective cohort study. J Am Geriatr Soc 2011; 59: 1369-1375.
38. Kannel WB, Wolf PA, Benjamin EJ, Levy D,. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82: 2N-9N
39. Thacker EL, McKnight B, Psaty BM, Longstreth WT, Jr, Sitlani CM, Dublin S, Arnold AM, et al. Atrial fibrillation and cognitive decline: A longitudinal cohort study. Neurology 2013; 81: 119-125.
40. Lepic T, Loncar G, Bozic B, Veljancic D, Labovic B, Krsmanovic Z, Lepic M, et al. Cerebral blood flow in the chronic heart failure patients. Perspect Med 2012; 1: 304-308.
41. Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane PK, Montine TJ, et al. Neuropathologic changes associated with atrial firbrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 2014; 69: 609-615.
42. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 1995; 92: 2178-2182
43. Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V,. Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis 2011; 26: 123-133.
44. rd. Link between heart disease, cholesterol, and Alzheimer's disease: A review. Microsc Res Tech 2000; 50: 287-290.
45. Kamishirado H, Inoue T, Fujito T, Kase M, Shimizu M, Sakai Y, Takayanagi K, et al. Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology 1997; 48: 707-713.
46. Stanek KM, Guntad J, Spitznagel MB, Waechter D, Hughes JW, Luyster F, Josephson R, et al. Improvements in cognitive function following cardiac rehabilitation for older adults with cardiovascular disease. Int J Neurosci 2011; 121: 86-93.
47. Park H, Hildreth A, Thomson R, O'Connell J,. Non-valvular atrial fibrillation and cognitive decline: A longitudinal cohort study. Age Ageing 2007; 36: 157-163.
48. Mannolis AG, Katsivas AG, Lazaris EE, Vassilopoulos CV, Louvros NE,. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Interv Card Electrophysiol 1998; 2: 71-76.
49. Leclercq C, Walker S, Linde S, Clementy J, Marshall AJ, Ritter P, Djiane P, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-1787.
50. Efimova I, Elimova N, Chernov V, Popov S, Lishmanov Y,. Ablation and pacing: Improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates. Pacing Clin Electrophysiol 2012; 35: 320-326.
51. Haeusler KG, Koch L, Herm J, Kopp UA, Heuschmann PU, Endres M, Schultheiss HP, Schirdewan A, Fiebach JB,. 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: Results of the MACPAF study. J Cardiovasc Electrophysiol 2013; 24: 14-21.
52. Herm J, Fiebach JB, Koch L, Kopp UA, Kunze C, Wollboldt C, Brunecker P, Schultheiss HP, Schirdewan A, Endres M, Haeusler KG,. Neuropsychological effects of MRI-detected brain lesions after left atrial catheter ablation for atrial fibrillation: Long-term results of the MACPAF study. Circ Arrhythm Electrophysiol 2013; 6: 843-850.
53. Bellomo A, De Benedetto G, Fossati C, D'Ottavio E, Formosa V, Gianturco V, Lori A, Marigliano B, Lo Lacono C, Troisi G, Marigliano V,. Atrial fibrillation (AF) and cognitive impairment in the elderly: A case-control study. Arch Gerontol Geriatr 2012; 55: 247-250.
54. Petersen P,. Thromboembolic complications in atrial fibrillation. Stroke 1990; 21: 4-13.
55. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ,. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010; 55: 725-731.